OSTEOSTRATA

Confidential Discussions

Tell us where your osteoarthritis programme needs greater clarity.

We work with biotechnology companies, pharmaceutical teams, investors and academic spin-outs on confidential scientific, clinical, regulatory and strategic questions.

Initial discussion

An initial discussion allows us to understand the decision, identify the expertise required and determine whether we are the appropriate partner.

Email

advisory@osteostrata.org

LinkedIn

OsteoStrata

Europe office

Available on request.

United States contact

Available on request.

Submitting this form does not create an advisory relationship. Please do not provide patient-identifiable information.